Advertisement

Topics

U.S. regulator approves Teva migraine drug, shares rise

15:31 EDT 14 Sep 2018 | Reuters

Shares of Israeli drugmaker Teva Pharmaceutical Industries rose over 5 percent in after-hours trading on Friday after the U.S. Food and Drug Administration (FDA) approved sales of the company's new migraine treatment, a key drug Teva has been banking...

Original Article: U.S. regulator approves Teva migraine drug, shares rise

NEXT ARTICLE

More From BioPortfolio on "U.S. regulator approves Teva migraine drug, shares rise"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...